Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000625901 | SCV000746480 | pathogenic | Neu-Laxova syndrome 1 | 2017-12-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000798475 | SCV000938093 | pathogenic | PHGDH deficiency | 2024-04-15 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg344*) in the PHGDH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PHGDH are known to be pathogenic (PMID: 14645240, 24836451). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with PHGDH-related conditions. ClinVar contains an entry for this variant (Variation ID: 522743). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000625901 | SCV001521892 | likely pathogenic | Neu-Laxova syndrome 1 | 2020-06-09 | criteria provided, single submitter | clinical testing | This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Revvity Omics, |
RCV001784181 | SCV002018777 | pathogenic | not provided | 2021-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000625901 | SCV004049108 | likely pathogenic | Neu-Laxova syndrome 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000798475 | SCV004049109 | likely pathogenic | PHGDH deficiency | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genomic Medicine Center of Excellence, |
RCV000798475 | SCV004804715 | pathogenic | PHGDH deficiency | 2024-03-17 | criteria provided, single submitter | research |